NUMA1 and neoplasm: Studies have evaluated tumour-associated cellular antigens (ImmunoCyt/uCyt+) [32], chromosomal anomalies (UroVysion) [33], nuclear matrix protein-22 [34], hCFHrp (BTA stat) [35], DNA analysis, and genetic mutations (EpiCheckTM) [36,37,38,39].